These studies will assess whether the pre-administration of CX717 can prevent the development of respiratory depression (RD) induced by the potent Schedule II opiate agonist, alfentanil. The first
The price of the acquisition is E12 million, of which E9 million were paid upon signing the agreement while E3 million are due over a period of three
Kodiak Venture Partners led the round and was joined by Catalyst Health Ventures and Boston University. In conjunction with the financing, Andrey Zarur, general partner with Kodiak Venture
Under the agreement, Abbott will develop a test to detect extra copies of the epidermal growth factor receptor gene using its proprietary fluorescence in situ hybridization technology in
Under terms of the agreement, Daiichi Sankyo will receive upfront payments, payments pursuant to the achievement of certain milestones, and royalties on product sales. Raymond Warrell, Jr., chairman
The MAA will be reviewed by the Committee for Medicinal Products for Human Use (CHMP), subject to validation by the European Medicines Agency. Aztreonam lysine is an investigational
This partnership follows an agreement signed in 2007 between Galderma and Zars Pharma for the promotion and distribution of Pliaglis in the US and Canada. Humberto Antunes, CEO
The panel has ruled that the patents covering the active ingredient and a pharmaceutical composition thereof are valid, enforceable and infringed by the generic manufacturer’s product. In the
Pharmion shareholders will receive $25 in cash and 0.84 Celgene shares for each share of Pharmion stock owned. The transaction brings together three medically meaningful therapies, Revlimid, Thalomid
After completing its review and delivering a report of its findings to Neuro-Hitech, Numoda will also assist the company in interpreting and presenting the results to potential licensing
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.